Auna S.A. expands oncology services with new partnershi

MONTERREY, Mexico - Auna S.A. (NYSE: AUNA), a healthcare company with operations across Latin America valued at $587 million, has announced a five-year exclusive agreement with Opción Oncología, a leading oncology clinic in Monterrey. The company, which has demonstrated strong revenue growth of 19% over the last twelve months, appears slightly undervalued according to InvestingPro analysis. This partnership, revealed today, is a strategic move by Auna to become the top oncology provider in Mexico and to consolidate its oncology services in the region. InvestingPro data shows positive analyst sentiment, with two analysts recently revising earnings expectations upward for the upcoming period.

The agreement will see eight prominent physicians, including six oncologists and two radiation oncologists, integrate their practice into Auna’s network. This team currently manages around 30% of Monterrey’s private oncology treatments. Auna plans to centralize 100% of these treatments within its facilities over time, aiming to improve care coordination and patient experience.

These physicians will move their practice to Doctors Hospital, enhancing Auna’s oncology capabilities. The shift is expected to elevate Auna’s Oncology Center to one of the few multidisciplinary and fully integrated oncology centers in Mexico’s private healthcare sector. Among the doctors joining Auna are Dr. César González de León and Dr. Cuauhtémoc De la Peña Hinojosa, who are highly regarded in their field. Dr. González will assume a leadership role as Chair of Medical Oncology and Co-Chair of the practice at Auna’s Center of Excellence in Oncology in Mexico. Dr. De la Peña Hinojosa will become Chair of Radiation Oncology on Auna Mexico’s Oncology Board.

This collaboration is part of Auna’s continued expansion in Mexico and follows the launch of OncoMexico last year. It also coincides with the upcoming inauguration of Auna’s Oncology Research Center in Mexico, which will collaborate with Auna’s existing research centers in Peru and Colombia to drive clinical research and advance cancer treatment in the region.

Suso Zamora, Executive Chairman and President of Auna, commented on the significance of the partnership for Auna’s growth in Mexico and its alignment with the company’s mission to offer superior cancer care. Dr. González de León and Dr. De la Peña Hinojosa expressed their enthusiasm for joining Auna’s mission and the opportunity to improve patient care and set new standards in oncology treatment.

The information is based on a press release statement. With Auna’s upcoming earnings report scheduled for March 10, InvestingPro subscribers can access additional insights, including 5 more exclusive ProTips and comprehensive financial analysis that could help evaluate the impact of this strategic partnership on the company’s future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.